In the leptin subsample (N = 602), leptin was not independently associated with advanced lesions (per doubling IRR: 0.85 unadjusted; 0.96 age/sex-adjusted; 0.95 fully adjusted) and did not materially alter MetS estimates. This evidence concerns the gene LEP and metabolic syndrome.